- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about CPRX
Recent news which mentions CPRX
From Benzinga
Earnings Scheduled For March 16, 2022
March 16, 2022
From Benzinga
From Benzinga
47 Biggest Movers From Yesterday
February 08, 2022
From Benzinga
Catalyst Pharma Expects FY22 Revenue Beat Consensus On Continued Recovery In Macroeconomic, Healthcare Activity
February 07, 2022
Tickers
CPRX
From Benzinga
7 of the Top-Rated Pharmaceutical Stocks for Q1
January 18, 2022
From InvestorPlace
The Top 3 Robinhood Stocks of 2021
January 07, 2022
From InvestorPlace
10 Top Robinhood Stocks That Doubled in 2021: Are They Buys Now?
December 31, 2021
From Motley Fool
2 Under-the-Radar Biotech Picks to Buy For The Long Haul
December 24, 2021
From Motley Fool
2 Top Healthcare Stocks Ready for a Bull Run in 2022
December 20, 2021
From Motley Fool
If You Invested $1,000 In Catalyst Pharmaceuticals Stock One Year Ago, Here's How Much You'd Have Now
November 30, 2021
From Benzinga
Catalyst Pharmaceuticals, inc (CPRX) Q3 2021 Earnings Call Transcript
November 10, 2021
Tickers
CPRX
From Motley Fool
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
From Benzinga
3 Low-Priced Stocks That Make Smart Bets
November 08, 2021
From InvestorPlace
How to Invest in Biotech Stocks in a Bear Market
October 13, 2021
From Motley Fool
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
Why Are Catalyst Pharma Shares Trading Higher On Thursday?
September 30, 2021
Tickers
CPRX
From Benzinga
5 Value Stocks To Watch In The Healthcare Sector
September 27, 2021
From Benzinga
Catalyst Pharmaceuticals's Return On Capital Employed Overview
September 15, 2021
Tickers
CPRX
From Benzinga
From InvestorPlace
Tickers
CPRX
From Motley Fool
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
From Benzinga
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
August 04, 2021
From Benzinga
3 Top Robinhood Stocks to Buy in August Instead of Dogecoin
August 01, 2021
From Motley Fool
Do Earnings Reports Matter for Biotech Stocks?
July 24, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.